Syphilis is a disease caused by a tiny, specific bacterium called T. pallidum. In addition to causing syphilis, this pathogen can also cause other diseases such as bejel and yaws. T. pallidum is unique not only in its morphology and biology, but also in its transmission route, infection mechanism and ability to evade the host immune system.
T. pallidum is a microaerophilic, Gram-negative, spiral-shaped bacterium, approximately 6 to 15 micrometers in length and 0.1 to 0.2 micrometers in width. It is unique in that the bacterium lacks the metabolic processes of the tricarboxylic acid cycle and oxidative phosphorylation, which makes its metabolic activity minimal. T. pallidum is an absolute parasite that enters the host primarily through contact with humans or apes.
T. pallidum's evasion of host immune defenses due to its tiny genome and unique outer membrane structure is the key to its hidden pathogenicity.
Three subspecies of T. pallidum, T. p. pallidum, T. p. endemicum, and T. p. pertenue, are responsible for the onset of syphilis, bejel, and yaws, respectively. These subspecies are morphologically and serologically indistinguishable but can be identified genetically. Unlike other bacteria, T. pallidum has very low levels of outer membrane proteins, which allows the bacterium to effectively evade the host's immune system response.
T. pallidum has a unique outer membrane structure that lacks the lipopolysaccharide of traditional bacteria, making it more hidden after entering the host. In addition, the outer membrane protein of this bacterium has low antigenicity and can effectively reduce recognition by the host immune system.
T. pallidum is known as a "stealth pathogen" because of the unique structure of its outer membrane protein, which allows it to hide from the host's immune system.
The clinical presentation of syphilis varies over the course of the disease, and rashes and other symptoms may appear at different stages. The disease is usually highly treatable with antibiotics such as penicillin, especially in the early stages. However, T. pallidum has also become increasingly resistant to some antibiotics, leading to a greater need for appropriate treatment options.
With the advancement of science, research on T. pallidum has gradually deepened. Its cultivation in the laboratory remains a challenge, and the successful cultivation reported in 2017 undoubtedly paved the way for understanding its biological characteristics, but the bacterium still shows strong host adaptability.
According to reports, there is currently no syphilis vaccine available, which poses a major public health challenge.
The unique features of T. pallidum make it stand out among bacteria, showing its speciality both in biological characteristics and clinical significance. As our understanding of this pathogen deepens, will we be able to find an effective way to treat syphilis?